Login to Your Account



Newco News

Ignyta's Combo Drug/Diagnostics Strategy a Differentiator

By Marie Powers
Staff Writer

Monday, July 22, 2013
A small biotech buy earlier this year could someday reap big rewards for Ignyta Inc., a San Diego firm that is integrating targeted drug discovery and development with companion diagnostics for patient stratification.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription